Spermicides

Infertility and Reproductive Medicine Clinics of North America

Volumn 11, Issue 4, 2000, Pages 657-667

  Mauck, C ^a   Doncel, G F ^a  

^a Contraceptive Res/Devmt Program ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NONOXINOL 9; SPERMICIDAL AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BIRTH CONTROL; CONTRACEPTION; COST EFFECTIVENESS ANALYSIS; FERTILIZATION; HUMAN; REVIEW; SEXUALLY TRANSMITTED DISEASE; SPERMATOZOON MOTILITY; SPERMATOZOON PENETRATION; UTERINE CERVIX MUCUS; VAGINA EPITHELIUM;

EID: 0033815836     PISSN: 10479422     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (64)

1. Characterization of cysteamine as a potential contraceptive anti-HIV agent
2. The diaphragm with and without spermicide: A randomized, comparative efficacy trial
3. Acrosin inhibitor, 4-acetamidophenyl 4-guanidinobenzoate, an experimental vaginal contraceptive with anti-HIV activity
4. Hydrophobe modified cationic polysaccharides for topical microbicide delivery
5. New and existing spermicides with virucidal properties
6. Changes in cervical mucus that prevent penetration by spermatozoa
7. AIDS and reproductive health
8. The pharmacodynamics and efficacy of Implanon: An overview of the data
9. Women's interest in vaginal microbicides
10. Aryl phosphate derivatives of bromomethoxy-azidothymidine are dual-function spermicides with potent antihuman immunodeficiency virus
11. Novel vaginal controlled-delivery systems incorporating coprecipitates of nonoxynol 9
12. Chemical vaginal contraceptives preclinical evaluation
13. Cervical mucus penetration assays in assisted reproduction
14. Studies on the in vitro spermicidal activity of synthetic magainins
15. Multiple actions of a novel vaginal contraceptive compound, ORF 13904
16. Contraceptive failure rates: New estimates from the 1995 National Survey of Family Growth
17. Protective effect of a thermoreversible gel against the tonicity of N-9
18. Global prevalence and incidence estimates of selected curable STDs
19. Plantibodies: Human antibodies produced by field crops enter clinical trials
20. The challenge of HIV/AIDS in Sub-Saharan Africa
21. Women's preferences for vaginal antimicrobial contraceptives II
22. Contraceptive efficacy
23. Solubilization of membranes by detergents
24. Biochemical characterization of sperm agglutination antigen-1, a human sperm surface antigen implicated in gamete interactions
25. Relative antifertility activity of three vaginal contraceptive products in the rabbit: Relationship to in vitro data
26. Contraceptive effects of intravaginal application of acrosin and hyaluronidase inhibitors in rabbits
27. Vaginal contraceptive activity of aryl 4-guanidinobenzoates (acrosin inhibitors) in rabbits
28. Virucidal effect of stimulated eosinophils on human immunodeficiency virus type 1
29. Acrosome reaction
30. Is the fetus safe when spermicides fail?
31. In vitro permeation study of a mucoadhesive drug delivery system for controlled delivery of nonoxynol 9
32. Comparative in vitro spermicidal activity of chelating agents and synergistic effect with nonoxynol 9 human sperm functionality
33. Carrageenan-based nonoxynol 9 spermicides for prevention of sexually transmitted infections
34. Fucoidin inhibits the zona pellucida-induced acrosome reaction in human spermatozoa
35. Effect of phosphorylated hesperidin, a hyaluronidase inhibitor, on fertility in the rat
36. Safety of a nonoxynol-9 vaginal gel in Kenyan prostitutes
37. Investigations into the mechanism by which sulfated polysaccharides inhibit HIV infection in vitro
38. The influence of nonoxynol-9-containing spermicides on urogenital infection
39. Biological and biochemical aspects of prevention of fertilization by enzyme inhibitors
40. Trends in contraceptive use in the United States: 1982-1995
41. Effects of gossypol on the motility of mammalian sperm
42. Effects of the prostanoid receptor antagonist, DI-4-phloretin phosphate, upon human sperm motility
43. Contraceptive effectiveness of two spermicides: A randomized trial
44. The suppression of contraceptive information
45. Providing clinics
46. A randomized controlled trial comparing nonoxynol-9 lubricated condoms with silicone lubricated condoms for prophylaxis
47. A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases
48. Acylcarnitine analogues as topical, microbicidal spermicides
49. Fertilization
50. Ultrastructure of human spermatozoa in the presence of the spermicide nonoxynol-9 and a vaginal contraceptive containing nonoxynol-9
51. Effectiveness of the nonspermicidal fit-free diaphragm
52. Spermicidal agents: Effectiveness, use and testing
53. Safety study of nonoxynol-9 as a vaginal microbicide: Evidence of adverse effects
54. Bacterial vaginosis and disturbances of vaginal flora: Association with increased acquisition of HIV
55. Assessment of the antimicrobial agent C31G as a spermicide: Comparison with nonoxynol 9
56. The economic value of contraception: A comparison of 15 methods
57. Comparative contraceptive efficacy of the female condom and other barrier methods
58. Contraceptive failure, method-related discontinuation and resumption of use: Results for the 1995 National Survey of Family Growth
59. Safety evaluation of nonoxynol-9 gel in women at low risk of HIV infection
60. Spermicidal activity of magainins: In vitro and in vivo studies
61. Contraceptive effect of sperm-agglutinating monoclonal antibodies in rabbits
62. Scanning electron microscopy of human spermatozoa after incubation with the spermicide nonoxynol-9
63. Spermicidal activity-structure relations of nonoxynol oligomers: Physicochemical basis